These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24687598)

  • 1. Packaging, amplification, and appraisal of the recombinant tumor-selective type I herpes simplex virus carrying GALV.fus gene.
    Bing Z; Jianru Y; Yuequan J; Shifeng C; Xinping F
    Cell Biochem Biophys; 2014 Sep; 70(1):321-6. PubMed ID: 24687598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The construction of recombinant type I herpes simplex virus carrying GALV.fus gene and its antitumor effect in nude mice].
    Zhu M; Yang JR; Jiang YQ; Chen SF; Fu XP; Tian ZD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):152-6. PubMed ID: 21500543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy of lung adenocarcinoma using herpes virus expressing a fusogenic membrane glycoprotein.
    Zhu B; Yang JR; Jiang YQ; Chen SF; Fu XP
    Cell Biochem Biophys; 2014 Jul; 69(3):583-7. PubMed ID: 24510538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor effects of gene therapy with GALV membrane fusion glycoprotein in lung adenocarcinoma.
    Zhu B; Yang JR; Fu XP; Jiang YQ
    Cell Biochem Biophys; 2014 Jul; 69(3):577-82. PubMed ID: 24519667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals.
    Berthomme H; Fournel S; Epstein AL
    Virology; 1996 Feb; 216(2):437-43. PubMed ID: 8607275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect.
    Fu X; Tao L; Jin A; Vile R; Brenner MK; Zhang X
    Mol Ther; 2003 Jun; 7(6):748-54. PubMed ID: 12788648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
    Zhang J; Frolov I; Russell SJ
    J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors.
    Saeki Y; Ichikawa T; Saeki A; Chiocca EA; Tobler K; Ackermann M; Breakefield XO; Fraefel C
    Hum Gene Ther; 1998 Dec; 9(18):2787-94. PubMed ID: 9874276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction and identification of HSV-1 vector vaccine carrying HIV-1 antigen].
    Zhao X; Guo J; Liu X; Ma Z
    Sheng Wu Gong Cheng Xue Bao; 2015 Mar; 31(3):384-93. PubMed ID: 26204759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus clearance during purification of a recombinant adeno-associated virus serotype 1 vector.
    Ye GJ; Scotti MM; Thomas DL; Wang L; Knop DR; Chulay JD
    Hum Gene Ther Clin Dev; 2014 Dec; 25(4):212-7. PubMed ID: 25357151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
    Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modest increases in the titers of helper virus-free herpes simplex virus 1 (HSV-1) vectors by packaging in a cell line with inducible expression of HSV-1 VP16 or by treatment with N,N'-hexamethylene-bis-acetamide.
    Sun M; Lee J; Yu L; Geller AI
    Acta Virol; 2000 Dec; 44(6):365-9. PubMed ID: 11332280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of retroviral vectors based on the gibbon ape leukemia virus.
    Eglitis MA; Schneiderman RD; Rice PM; Eiden MV
    Gene Ther; 1995 Sep; 2(7):486-92. PubMed ID: 7584127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSV-1 infected cell proteins influence tetracycline-regulated transgene expression.
    Herrlinger U; Pechan PA; Jacobs AH; Woiciechowski C; Rainov NG; Fraefel C; Paulus W; Reeves SA
    J Gene Med; 2000; 2(5):379-89. PubMed ID: 11045432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved titers for helper virus-free herpes simplex virus type 1 plasmid vectors by optimization of the packaging protocol and addition of noninfectious herpes simplex virus-related particles (previral DNA replication enveloped particles) to the packaging procedure.
    Sun M; Zhang GR; Yang T; Yu L; Geller AI
    Hum Gene Ther; 1999 Aug; 10(12):2005-11. PubMed ID: 10466634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for acute myeloid leukemia using Sindbis vectors expressing a fusogenic membrane glycoprotein.
    Tan L; Xu B; Liu R; Liu H; Tan H; Huang W
    Cancer Biol Ther; 2010 Mar; 9(5):350-7. PubMed ID: 20061812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinase.
    Logvinoff C; Epstein AL
    Virology; 2000 Feb; 267(1):102-10. PubMed ID: 10648187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro ligation and transfection system for inserting DNA sequences into the latency-associated transcripts (LATs) gene of herpes simplex virus type 1.
    Huang QS; Deshmane SL; Fraser NW
    Gene Ther; 1994 Sep; 1(5):300-6. PubMed ID: 7584095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display.
    Fielding AK; Chapel-Fernandes S; Chadwick MP; Bullough FJ; Cosset FL; Russell SJ
    Hum Gene Ther; 2000 Apr; 11(6):817-26. PubMed ID: 10779159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.